Bellast dermal filler: Clinical guide and consent form template

Key Takeaways

Bellast is a cross-linked hyaluronic acid dermal filler manufactured by Dongkook Pharmaceutical, a South Korean pharmaceutical company, and it ships in six formulations, from Soft L to Ultra Plus, for different injection depths.

Product selection depends on treatment depth and area: Ultra Plus for structural augmentation, Ultra L for deep volumizing, Soft L or Plus for superficial lines and lip enhancement.

Pre-treatment screening should document contraindications, such as autoimmune conditions, active skin infection, and anticoagulant use, plus current medications and prior filler history.

Practice management software like Pabau can capture digital consent, log injection details, and automate aftercare messages, giving you batch-level traceability for every Bellast procedure.

Choosing a filler line usually means a compromise. You pick a soft gel for fine lines, then a firmer one for structure, and end up stocking both. Bellast was built to avoid that. It is one hyaluronic acid range in several densities. That means a single line can cover lips, cheeks, and jaw in one appointment. The flexibility is the real appeal.

Still, it only pays off when you match each variant to the right depth, screen carefully, and document what you used. Get those habits right, and Bellast is easy to run. So let’s start with what it actually is, and where it fits in your lineup.

What Bellast is, and where it fits in your filler lineup?

Bellast is a cross-linked hyaluronic acid dermal filler made by Dongkook Pharmaceutical, a South Korean pharmaceutical company. Med spas, dermatology practices, and aesthetic practices use it for facial volumizing, contouring, and lip augmentation.

Unlike single-formulation fillers, Bellast ships in six variants tuned to different injection depths, so one product line can cover lips, cheeks, and jawline in the same treatment plan.

The product carries CE marking under EU medical device regulations, meeting the Class III bar set by the 2021 MDR update. Regulatory status shifts by market, though, so confirm whether Bellast currently qualifies for CE marking in Great Britain or needs UKCA marking before you order stock.

Whatever the market, the workflow looks the same: consultation, screening, signed consent, then injection. Using digital consent forms during that consultation keeps a clear record of what the patient agreed to and what you told them about risk, which matters as much for compliance as it does for the conversation itself.

Bellast product range: Formulations and indications

Understanding each Bellast variant’s rheological properties and intended use is key to safe, consistent outcomes. The lineup covers every layer of facial anatomy, from superficial fine lines to structural augmentation of the midface and lower face.

Every Bellast variant uses BDDE (1,4-butanediol diglycidyl ether) cross-linking to improve durability while keeping results looking natural.

Practitioners should keep structured treatment records that log the product variant, batch number, volume injected, and treatment area for each patient. That documentation is what makes batch traceability possible if a recall or adverse event ever comes up.

Bellast Ultra L: Indications and injection protocol

Bellast Ultra L is the workhorse formulation for deep facial volumizing. Its high viscosity and large cross-linked particle matrix provide lift and structural support. That makes it a solid choice for cheek augmentation, chin projection, and jawline contouring.

1. Injection depth: Place Ultra L in the deep dermal to subcutaneous plane, above periosteum when you need bone-level support.
2. Cannula preferred: A 25-27G blunt-tip cannula lowers vascular trauma and bruising risk compared with needle injection.
3. Volume per session: Cheeks typically take 1-2 mL per side, chin augmentation 0.5-1.5 mL, and jawline contouring 1-2 mL distributed along the mandibular border.
4. Layering technique: Inject slowly in small boluses along the anatomical plane for even distribution and support.

Ultra L longevity runs approximately 9-12 months, depending on patient metabolism and injection depth. Document expected re-treatment intervals in your patient portal so reminders go out automatically and you capture outcome data over time.

Bellast Ultra Plus: A deep-volume case example

Ultra Plus is the thickest Bellast formulation, built for severe volume loss and non-surgical facial rejuvenation. Take a typical case: a patient in her late fifties with midface ptosis from age-related fat pad atrophy. Her cheeks have flattened, her temples look hollow, and her jawline has lost definition.

For a patient like this, Ultra Plus goes into the subcutaneous layer or just above the periosteum. Use a cannula rather than a needle here, since it lowers the risk of vascular occlusion in these deeper planes. Results build over two to four weeks as swelling resolves, so book her review for week four, not week one, and say so before you inject, not after.

Longevity for Ultra Plus runs approximately 12-18 months. Patients with more volume loss to correct, like this one, tend to land toward the longer end of that range. Ultra Plus rewards patience: it works best when patients understand results take a few weeks to settle and then hold for over a year.

Bellast for lip augmentation: Technique and patient selection

Lip augmentation with Bellast calls for a different approach than facial volumizing. Lip tissue is highly mobile, thin-walled, and vascularly rich, so it demands careful technique and patient selection.

Product selection: Use Bellast Soft L or Plus for lip enhancement. Soft L suits subtle definition and softening fine lip lines, while Plus works better for moderate augmentation and defining the vermillion border.

1. Pre-treatment assessment: Check lip symmetry and existing vermillion height against the patient’s goals, using reference images or before-and-after documentation to track results over time.
2. Injection plane: Inject in the dermis, superficial to mid-dermal, for lip line definition. Go deeper into the submucosa for volumizing the lip body.
3. Distribution: Serial puncture or small linear threading works well. Around 0.5-1 mL per lip is usually enough to avoid over-inflation and keep proportions natural.
4. Post-injection massage: A gentle massage after injection distributes product evenly and reduces lumpiness.

Bellast in the lips lasts 8-12 months on average, shorter than facial applications because lip tissue is more mobile and metabolically active. Set that expectation early, and schedule a follow-up consultation around month 10 or 11 to plan re-treatment timing.

Bellast pre-treatment checklist for practitioners

A thorough pre-treatment assessment keeps Bellast injections safe. Work through a standard checklist to document contraindications, medical history, and baseline skin condition before you pick up a needle, and talk the patient through each step as you go so consent covers what you actually found.

• Absolute contraindications (do not treat): Active skin infection or herpes simplex outbreak, known allergy to hyaluronic acid or lidocaine, severe uncontrolled bleeding disorder, active chemotherapy, severe immunosuppression, pregnancy or active breastfeeding.
• Relative contraindications (use caution): Anticoagulation therapy or high-dose NSAIDs (raise bruising and bleeding risk), isotretinoin use within 6 months, history of severe hypertrophic scarring or keloids, unrealistic patient expectations, history of prior filler complications.
• Medical history red flags: Autoimmune conditions (especially lupus, scleroderma), recent facial surgery (<4 weeks), history of severe migraine triggered by facial pressure.
• Skin assessment: Document skin type, existing wrinkles or folds, asymmetry, and any active lesions or infection. Take baseline photos through your practice management software for comparison and medico-legal protection.

Common mistakes practitioners make with HA fillers like Bellast

Most Bellast complications trace back to a handful of avoidable habits, not the product itself. Watch for these before they turn into a difficult phone call.

• Mismatching product to depth: Reaching for Soft L when a patient needs structural support, or using Ultra Plus on fine perioral lines, gives uneven or overcorrected results.
• Skipping the screening conversation for returning patients: Medications and health status change between visits. Re-screen every time, even for a patient you treated last month.
• Not having hyaluronidase on hand: Keep it in the room, not in a storeroom, so you can act immediately if vascular compromise shows up.
• Overpromising same-day results: Swelling takes two to four weeks to settle, especially with the thicker formulations. Say so up front, so the patient does not judge the outcome too early.
• Loose batch documentation: Logging the batch number after the patient has left makes errors likely. Record it during the visit, while the vial is still in your hand.

Aftercare instructions template for Bellast dermal filler

Clear, product-specific aftercare instructions cut down on post-treatment complications and keep patients happier with their results. Give instructions both in print and electronically, through the patient portal, right after treatment for the best compliance.

• First 24 hours: Avoid touching, rubbing, or pressing on treated areas. Skip strenuous exercise, saunas, hot water immersion, and alcohol, since all of these increase swelling and bruising.
• Days 2-7: Gentle facial massage is fine if swelling persists. Ice packs (15 minutes on, 15 minutes off) help with residual swelling. Hold off on facial treatments such as microdermabrasion, chemical peels, or laser for at least 2 weeks.
• Medications: Avoid extra blood thinners. Topical arnica or bromelain supplements can help reduce bruising in patients who bruise easily.
• Expected side effects: Mild swelling, bruising, tenderness, and asymmetry are normal and usually resolve within 1-2 weeks. Redness and firmness can persist for 24-48 hours.
• When to contact the practice: Signs of spreading infection (warmth, pus, fever), vascular compromise (blanching or darkening skin), a severe allergic reaction (hives, difficulty breathing), or nodules that persist beyond 4 weeks.

Use automated messaging workflows to send aftercare reminders the day after treatment and again at 1 week and 2 weeks, so instructions stay top of mind and compliance holds up.

Bellast vs Juvederm: Key differences for practitioners

Juvederm (Allergan/AbbVie) remains the gold-standard filler worldwide, but Bellast is a genuine alternative on cost, formulation range, and rheological performance. Here is how they stack up for a practitioner deciding between them.

Both fillers are safe, effective, and reversible. The choice between them usually comes down to practitioner familiarity, cost structure, and what a given patient needs.

Bellast’s multi-formulation range suits practitioners who want flexibility within one product line, while Juvederm’s market presence offers wider patient recognition and a well-established supply chain.

How Pabau streamlines Bellast consent, records, and aftercare

Practice management software like Pabau turns that workflow into fewer manual steps.

• Send the Bellast consent form by SMS or email before the appointment, and the patient’s answers populate their clinical record automatically, with no re-typing required.
• Log the product variant and batch number against each treatment, so if a batch is ever recalled, you can pull every patient who received it in seconds instead of searching paper charts.
• Before-and-after photos attach to the same record, so you can track results across visits without a separate app.

Once the patient leaves, automated messages handle the aftercare reminders, at 24 hours, then again at one and two weeks, so follow-up does not depend on staff remembering.

Together, that covers the three things that matter most here: careful screening, batch-level documentation, and aftercare patients actually read.

Making Bellast work in your practice

Bellast gives aesthetic practitioners a flexible, multi-formulation hyaluronic acid platform for a wide range of facial anatomy and treatment depths.

From subtle lip definition with Soft L to structural volumizing with Ultra Plus, the range covers most of what a filler practice needs, without stocking several competing brands. Safe, compliant Bellast practice comes down to three things: careful pre-treatment screening, batch-level documentation, and clear aftercare communication. Get those three right, and the product does the rest.

See how Pabau makes Bellast consent management and aftercare delivery seamless

Capture consent, track product batches, and automate patient aftercare in one integrated workflow.

Book a demo

Continue your research

Need a consent template for a different treatment? The Dermaplaning Consent Form Template follows the same documentation workflow, adapted for a different procedure.

Screening for autoimmune conditions before treatment? C4 complement blood test: levels, ranges, and interpretation explains a test used to help investigate suspected lupus.

Checking vitals as part of your pre-treatment workup? Blood pressure monitoring: a complete clinical guide covers monitoring practices relevant to patients on anticoagulant therapy.

Frequently asked questions